Research ArticleOriginal Article
Open Access

Hematological malignancies

Prevalence and hematological characteristics in a single center in southern Saudi Arabia

Adil M. Alshahrani, Omayma S Bakheet, Mohammed H. Makkawi and Sultan Z. Alasmari
Saudi Medical Journal March 2024, 45 (3) 295-306; DOI: https://doi.org/10.15537/smj.2024.45.3.20230776

References

  1. 1.↵
    1. Ahmad S,
    2. Kifayatullah -,
    3. Shah KA,
    4. Hussain H,
    5. Haq AU,
    6. Ullah A
    , et al. Prevalence of acute and chronic forms of leukemia in various regions of khyberpakhtunkhwa, pakistan: Needs much more to be done. Bangladesh J Med Sci (Ibn Sina Trust) 2019; 18: 222-227.
    OpenUrl
  2. 2.↵
    1. Tebbi CK
    . Etiology of acute leukemia: A review. Cancers (Basel) 2021; 13: 2256.
    OpenUrl
  3. 3.↵
    1. Bispo JAB,
    2. Pinheiro PS,
    3. Kobetz EK
    . Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med 2020; 10: a034819.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Owaidhah NA,
    2. Khawaji ZY,
    3. Alahmadi MA,
    4. Badawi AS,
    5. Mogharbel GH,
    6. Makhdoom ON
    . Epidemiological trends and clinical characteristics of childhood leukemia in saudiarabia: A review. Curēus 2022; 14: e28178.
    OpenUrl
  5. 5.↵
    1. Bawazir A,
    2. Al-Zamel N,
    3. Amen A,
    4. Akiel MA,
    5. Alhawiti NM and
    6. Alshehri A
    . The burden of leukemia in the kingdom of saudiarabia: 15 years period (1999–2013). BMC Cancer 2019; 19: 1-10.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Shafique S and
    2. Tehsin S
    . Acute lymphoblastic leukemia detection and classification of its subtypes using pretrained deep convolutional neural networks. Technol Cancer Res Treat 2018; 17: 1533033818802789.
    OpenUrl
  7. 7.↵
    1. Shah A,
    2. Naqvi SS,
    3. Naveed K,
    4. Salem N,
    5. Khan MAU,
    6. Alimgeer KS
    . Automated diagnosis of leukemia: A comprehensive review. Access 2021; 9: 132097-132124.
    OpenUrl
  8. 8.↵
    1. Patel N,
    2. Mishra A
    . Automated leukaemia detection using microscopic images. Procedia Comput Sci 2015; 58: 635-642.
    OpenUrl
  9. 9.↵
    1. Daqqa KAA,
    2. Maghari AY and
    3. Al Sarraj WF
    . Prediction and diagnosis of leukemia using classification algorithms. Conference: 2017 8th International Conference on Information Technology (ICIT)At: Amman, Jordan.
  10. 10.↵
    1. Al-Amleh EK,
    2. Al-Sanabra OM,
    3. Alqaisi KM,
    4. Alqaraleh M,
    5. Al-Nahal J,
    6. Hamadneh L, et al.
    Investigation of the effect of imatinib and hydroxyurea combination therapy on hematological parameters and gene expression in chronic myeloid leukemia (CML) patients. J Clin Med 2022; 11: 4954.
    OpenUrl
  11. 11.↵
    1. Ibrahim R,
    2. Idrees N and
    3. Younis N
    . Epidemiology of leukemia among children in nineveh province, Iraq. Rawal Med J 2023; 48: 137-139.
    OpenUrl
  12. 12.↵
    1. Alhajori FS,
    2. Makkawi MH,
    3. Alasmari SZ,
    4. Shaikh AA and
    5. Baig MA
    . Estimating the prevalence of pediatric hematological malignancies in al-madinah al-munawwarah, saudiarabia. Saudi Med J 2023; 44: 504-508.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Jabbour E,
    2. Kantarjian H
    . Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring. American journal of hematology 2020; 95: 691-709.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Hu Y,
    2. Li Q,
    3. Hou M,
    4. Peng J,
    5. Yang X,
    6. Xu Shuqian
    . Magnitude and temporal trend of the chronic myeloid leukemia: On the basis of the global burden of disease study 2019. JCO Global Oncol 7: 1429.
  15. 15.↵
    1. Dong Y,
    2. Shi O,
    3. Zeng Q,
    4. Lu X,
    5. Wang W,
    6. Li Y, et al.
    Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol 2020; 9: 14.
    OpenUrl
  16. 16.↵
    1. Ul Haw A,
    2. Hussain H,
    3. Khan A,
    4. Ali KS,
    5. Rhman N,
    6. Ahmad S, et al.
    Prevalence of acute and chronic forms of leukemia in various regions of khyberpakhtunkhwa, pakistan: Needs much more to be done. Bangladesh J Med Sci (Ibn Sina Trust) 2019; 18: 222-227.
    OpenUrl
  17. 17.↵
    1. Newell LF and
    2. Cook RJ
    . Advances in acute myeloid leukemia. BMJ (Online) 2021; 375: n2026.
    OpenUrl
  18. 18.↵
    1. Ostasov P,
    2. Robertson H,
    3. Piazza P,
    4. Datta A,
    5. Apperley J,
    6. Houdova L, et al.
    Evolution of advanced chronic lymphoid leukemia unveiled by single-cell transcriptomics: A case report. Front Oncol 2020; 10: 584607.
    OpenUrl
  19. 19.↵
    1. Muhammad D,
    2. Khan I,
    3. Hussain Munir A and
    4. Khan MI
    . Pattern of basic hematological parameters in acute and chronic leukemias. J Med Sci 2019; 27: 125-129.
    OpenUrl
  20. 20.↵
    1. Perdani RRW and
    2. Sudarmanto B
    . Hematological parameters and remission induction of childhood acute lymphoblastic leukemia. Paediatr Indones 2018; 58: 71-74.
    OpenUrl
  21. 21.↵
    1. Almetairi KN,
    2. Alasmari SZ,
    3. Makkawi MH and
    4. Shaikh AA
    . Prevalence, hematological parameters, and coagulation profiles. Saudi Med J 2023; 44: 385-393.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Li T,
    2. Li X,
    3. Chen H,
    4. Huang K,
    5. Xie Q,
    6. Ge H, et al.
    Higher red blood cell distribution width is a poor prognostic factor for patients with chronic myeloid leukemia. Cancer Manag Res 2021; 13: 1233–1243.
    OpenUrl
  23. 23.↵
    1. Abdalla AA and
    2. Akasha R
    . Liver enzymes, urea and creatinine among acute lymphocytic leukemia in sudanese patients. Journal of Medical and Biological Science Research 2018; 4: 72-75.
    OpenUrl
  24. 24.↵
    1. Islam T,
    2. Rahman AKMS,
    3. Hasan MK,
    4. Jahan F,
    5. Mondal MC,
    6. Ferdoushi S, et al.
    Liver function tests in patients of acute leukemia before and after induction chemotherapy. J Biosci Med 2020; 8: 110-121.
    OpenUrl
  25. 25.↵
    1. Woike DP
    . Study of liver and kidney biochemical variations in patients with various morphological types of leukemia at a tertiary healthcare hospital. J Med Sci Clin Res 2018; 6: 2455-0450.
    OpenUrl
  26. 26.↵
    1. Jumaah HM,
    2. Yenzeel JH and
    3. Mehdi MG
    . Evaluation of some biochemical parameters and hormones in patients with acute myeloid leukemia in Iraq. Iraqi J Sci 2021; 62: 1460-1466.
    OpenUrl
  27. 27.↵
    1. Lad D,
    2. Jain A and
    3. Varma S
    . Complications and management of coagulation disorders in leukemia patients. Blood Lymphat Cancer 2017; 7: 61-72.
    OpenUrl
  28. 28.↵
    1. Dispenzieri A
    . POEMS syndrome: 2019 update on diagnosis, risk‐stratification, and management. Am J Hematol 2019; 94: 812-827.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Xu A,
    2. Liu P,
    3. Zhou F
    . Analysis of risk factors of coagulation dysfunction and hemorrhage in newly diagnosed hyperleukocytic acute myeloma leukemia. Contrast Media Mol Imaging 2022; 2022: 1-8.
    OpenUrl
  30. 30.↵
    1. Jain A,
    2. Gupta N,
    3. Singh T,
    4. Agarwal S
    . A study of haemostatic parameters in patients of chronic myeloid leukaemia. J Clin Diagn Res 2016; 10: OC19–OC23.
    OpenUrl
  31. 31.↵
    1. Osei-OWusu W,
    2. Ntiamoah DO,
    3. Akuffo GA,
    4. Mintaah S,
    5. Owusu M,
    6. Sackey B
    , et al. Coagulation abnormalities in childhood acute lymphoblastic leukemia: Assessing the impact of L-asparaginase therapy in ghana. Thromb J 2021; 19: 1-44.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords